Systematic Alpha Investments’s Edwards Lifesciences EW Stock Holding History

Systematic Alpha Investments’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$214K	Hold	2,670	–	–	0.01%	218
2025 Q4	$228K	Hold	2,670	–	–	0.01%	210
2025 Q3	$208K	Hold	2,670	–	–	0.01%	218
2025 Q2	$209K	Buy	+2,670	New	+$199K	0.01%	219
2024 Q3	–	Sell	-2,670	Closed	-$247K	–	230
2024 Q2	$247K	Hold	2,670	–	–	0.01%	198
2024 Q1	$255K	Hold	2,670	–	–	0.01%	203
2023 Q4	$204K	Hold	2,670	–	–	0.01%	211
2023 Q3	$185K	Hold	2,670	–	–	0.01%	209
2023 Q2	$252K	Hold	2,670	–	–	0.01%	198
2023 Q1	$221K	Buy	+2,670	New	+$210K	0.01%	202
2022 Q4	–	Sell	-2,670	Closed	-$221K	–	219
2022 Q3	$221K	Hold	2,670	–	–	0.01%	201
2022 Q2	$254K	Hold	2,670	–	–	0.01%	193
2022 Q1	$314K	Hold	2,670	–	–	0.02%	197
2021 Q4	$346K	Hold	2,670	–	–	0.02%	179
2021 Q3	$320K	Hold	2,670	–	–	0.01%	199
2021 Q2	$299K	Buy	2,670 +1,923	+257%	+$181K	0.01%	167
2021 Q1	$62K	Hold	747	–	–	﹤0.01%	153
2020 Q4	$68K	Buy	+747	New	+$62K	0.01%	115

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Systematic Alpha Investments's EW Position: Q1 2026 in Review

Systematic Alpha Investments held its Edwards Lifesciences (EW) position steady in Q1 2026 at 2,670 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #218.

Systematic Alpha Investments first reported a position in EW in Q4 2020 and has held it in 18 quarters since. The position peaked at $346K in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Systematic Alpha Investments held 2,670 shares of Edwards Lifesciences worth $214K as of Q1 2026.
Systematic Alpha Investments left its Edwards Lifesciences share count unchanged in Q1 2026.
Edwards Lifesciences made up 0.01% of Systematic Alpha Investments's portfolio in Q1 2026, its #218 holding.
Systematic Alpha Investments first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 18 quarters since.
Systematic Alpha Investments's Edwards Lifesciences position peaked at $346K in Q4 2021.
1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Systematic Alpha Investments's 13F filing for Q1 2026, filed 18 May 2026.